Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

The discovery of new chemical entities is a crucial part of drug discovery, which requires the lead compounds to have desired properties to be pharmaceutically active. De novo drug design aims to generate and optimize novel ligands for macromolecular targets from scratch. The development of graph-based deep generative neural networks has provided a new method. In this review, we gave a brief introduction to graph representation and graph-based generative models for de novo drug design, summarized them as four architectures, and concluded each's characteristics. We also discussed generative models for scaffold- and fragment-based design and graph-based generative models' future directions. Copyright © 2020 Elsevier Ltd. All rights reserved.


Xiaolin Xia, Jianxing Hu, Yanxing Wang, Liangren Zhang, Zhenming Liu. Graph-based generative models for de Novo drug design. Drug discovery today. Technologies. 2019 Dec;32-33:45-53

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 33386094

View Full Text